IP23-11: Prognostic Value of PSMA PET in Metachronous Oligometastatic Prostate Cancer

IP23-11: Prognostic Value of PSMA PET in Metachronous Oligometastatic Prostate Cancer

Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)

147A

Abstract

Speakers

Sebastian Hoberueck

Sebastian Hoberueck

Senior physician / Head of PET/CT & PET/MRDepartment of Nuclear Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Fetscherstraße 74, 01307 Dresden, Germany

Sessions

IP23: Prostate Cancer: Staging & Radiation Therapy

Friday, May 15, 2026 3:30 PM to 5:30 PM

Glen McWilliams · R Frank Jones Urological Society

Badar Mian · Albany Medical Center

Log in

See all the content and easy-to-use features by logging in or registering!